SciELO - Scientific Electronic Library Online

 
vol.26 issue3Assessment of limitations in rheumatology. Tools most used in practiceDermal necrosis as the first manifestation of anti-phospholipid antibody syndrome author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Abstract

CABRERA-SALOM, Carolina; MOTTA BELTRAN, Adriana  and  MEDINA, Yimy. Unusual presentation of psoriasis ostracea and psoriatic arthritis: Results after 10 years of infliximab treatment. Rev.Colomb.Reumatol. [online]. 2019, vol.26, n.3, pp.194-200.  Epub Aug 20, 2020. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2018.03.005.

Psoriasis is a common cutaneous disease with a world prevalence of 0.9-8.5%. It is a chronic, inflammatory, immune mediated condition that leads to epidermal hyperplasia and an array of clinical presentations. Psoriasis ostracea is a rare hyperkeratotic variant of psoriasis. Although frequently associated with psoriatic arthritis, there are few reports in the literature. Psoriatic arthritis is a chronic, seronegative, inflammatory arthritic disease, in which the symptoms usually emerge years after skin lesions appear. The case is presented of a patient, who after 10-years of adequate Infliximab treatment, had an unusual presentation of psoriatic arthritis associated with psoriasis ostracea.

Keywords : Psoriasis; Psoriatic arthritis; Infliximab.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )